Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

346
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

383
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
383
Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

842
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
842
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

786
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
786

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.

Clinical pharmacology and therapeutics·2017
Same author

Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension.

Journal of perinatology : official journal of the California Perinatal Association·2016
Same author

Research challenges in central nervous system manifestations of inborn errors of metabolism.

Molecular genetics and metabolism·2010
Same author

Spectrogoniometer for measuring planetary surface materials at small phase angles.

Applied optics·2010
Same author

Parental perception of time and decision-making in neonatal research.

Journal of perinatology : official journal of the California Perinatal Association·2009
Same author

The relationship between skin temperature and neuronal characteristics in the median, ulnar and radial nerves of non-impaired individuals.

Electromyography and clinical neurophysiology·2007

Related Experiment Video

Updated: Apr 9, 2026

Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain
08:26

Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain

Published on: July 1, 2019

7.2K

Microdosing Studies in Children: A US Regulatory Perspective.

M Roth-Cline1, R M Nelson1

  • 1Office of Pediatric Therapeutics, FDA, Silver Spring, Maryland, USA.

Clinical Pharmacology and Therapeutics
|June 23, 2015
PubMed
Summary

Pediatric microdosing studies provide crucial pharmacokinetic data. These studies help understand how metabolic enzymes develop and how drugs are processed in children.

Area of Science:

  • Pharmacology
  • Pediatric Drug Development
  • Drug Metabolism

Background:

  • Understanding drug behavior in children is vital for safe and effective therapeutics.
  • Pharmacokinetic (PK) data in pediatric populations is often limited.
  • Enzyme ontogeny and drug disposition pathways differ significantly from adults.

Purpose of the Study:

  • To elucidate pharmacokinetic profiles of drugs in pediatric populations.
  • To investigate the developmental trajectory of key drug-metabolizing enzymes.
  • To characterize drug disposition in children.

Main Methods:

  • Administration of sub-therapeutic doses (microdosing) of drugs.
  • Collection and analysis of biological samples (e.g., blood, urine).

More Related Videos

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

Related Experiment Videos

Last Updated: Apr 9, 2026

Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain
08:26

Non-Invasive Modulation and Robotic Mapping of Motor Cortex in the Developing Brain

Published on: July 1, 2019

7.2K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K
  • Application of sensitive bioanalytical techniques for drug quantification.

    • Main Results:

    • Acquisition of essential pharmacokinetic parameters (e.g., clearance, volume of distribution).
    • Insights into the maturation of specific metabolic pathways.
    • Characterization of absorption, distribution, metabolism, and excretion (ADME) in pediatric subjects.

    Conclusions:

    • Pediatric microdosing is a valuable tool for generating essential PK information.
    • This approach aids in understanding enzyme ontogeny and drug disposition.
    • Findings support improved pediatric drug dosing and development.